BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16403819)

  • 1. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
    de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
    J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional imaging of the pancreas: the role of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy.
    Ribeiro MJ; Boddaert N; Delzescaux T; Valayannopoulos V; Bellanné-Chantelot C; Jaubert F; Verkarre V; Nihoul-Fékété C; Brunelle F; Lonlay P
    Endocr Dev; 2007; 12():55-66. PubMed ID: 17923769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
    Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F
    J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiological innovations in the screening and diagnosis of the inborn errors of metabolism].
    Boddaert N; Ribeiro M; Touati G; Mention K; Valayanopoulos V; Nihoul-Fékété C; Brunelle F; de Lonlay P
    Med Sci (Paris); 2005 Nov; 21(11):981-6. PubMed ID: 16274650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
    Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism.
    Yang J; Yuan L; Meeks JK; Zhang N; Li C; Hao R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):619-22. PubMed ID: 23155683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
    Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
    Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography.
    Otonkoski T; Näntö-Salonen K; Seppänen M; Veijola R; Huopio H; Hussain K; Tapanainen P; Eskola O; Parkkola R; Ekström K; Guiot Y; Rahier J; Laakso M; Rintala R; Nuutila P; Minn H
    Diabetes; 2006 Jan; 55(1):13-8. PubMed ID: 16380471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
    Subramaniam RM; Karantanis D; Peller PJ
    J Comput Assist Tomogr; 2007; 31(5):770-2. PubMed ID: 17895790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
    J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism.
    Mohnike K; Blankenstein O; Minn H; Mohnike W; Fuchtner F; Otonkoski T
    Horm Res; 2008; 70(2):65-72. PubMed ID: 18547951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital hyperinsulinism treated by surgical resection of the hyperplastic lesion which had been preoperatively diagnosed by 18F-DOPA PET examination in Japan: a nationwide survey.
    Kanamori Y; Watanabe T; Yorifuji T; Masue M; Sasaki H; Nio M
    Pediatr Surg Int; 2018 Oct; 34(10):1093-1098. PubMed ID: 30076450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
    Tessonnier L; Sebag F; Ghander C; De Micco C; Reynaud R; Palazzo FF; Conte-Devolx B; Henry JF; Mundler O; Taïeb D
    J Clin Endocrinol Metab; 2010 Jan; 95(1):303-7. PubMed ID: 19915018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Feasibility of domestic (18)F-DOPA PET/CT scanning in the differential diagnosis of pancreatic lesions in children with hyperinsulinemic hypoglycemia].
    Zhang MY; Ge JJ; Pei Z; Dong KR; Chen L; Wang X; Zhang ZW; Li XJ; Xi L; Cheng RQ; Lu GP; Guan YH; Luo FH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):785-789. PubMed ID: 29050119
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
    Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
    Masue M; Nishibori H; Fukuyama S; Yoshizawa A; Okamoto S; Doi R; Uemoto S; Tokumi T; Kasai T; Yorifuji T
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):342-6. PubMed ID: 21521340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the use of [18F]DOPA as an imaging biomarker for transplanted islet mass.
    Eriksson O; Mintz A; Liu C; Yu M; Naji A; Alavi A
    Ann Nucl Med; 2014 Jan; 28(1):47-52. PubMed ID: 24166476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism.
    Garg PK; Putegnat B; Truong L; Reynolds C; Sanchez I; Nedrelow JK; Uffman J; Lokitz SJ; Nazih R; Garg S; Thornton PS
    PLoS One; 2020; 15(10):e0241243. PubMed ID: 33108363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.